For research use only
| Cat No. | ABC-TC3489 |
| Product Type | Cartilage Cells |
| Cell Type | Fibrosus Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Annulus Fibrosus |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Degeneration of the intervertebral disk is a major pathological process implicated in low back pain.
Human Annulus Fibrosus Cells (HAFCs) are primary cells isolated from healthy human intervertebral discs. These cells exhibit a characteristic fibroblast-like morphology and grow as adherent monolayers. Following primary culture, these cells are cryopreserved. They maintain critical fibrocartilaginous functions, actively synthesizing and organizing extracellular matrix (ECM) components, including collagen type I and type II and aggrecan to preserve disc biomechanical integrity. Their dysfunction has been shown to drive intervertebral disc degeneration (IDD) and chronic low back pain. These HAFCs express fibrocartilaginous markers collagen I, collagen II, and versican. As primary cells, they possess limited proliferative capacity. Repeated freezing and thawing should be avoided during culture. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | Human Annulus Fibrosus Cells, Intervertebral Disc Annulus Fibrosus Cells, AF Cells Human, Human Disc Fibrocartilage Cells, Annulus Fibrosus Fibroblasts |
| Species | Human |
| Cat.No | ABC-TC3489 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Fibrosus Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Annulus Fibrosus |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Cartilage Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human Annulus Fibrosus Cells serve as a critical in vitro model to study matrix degradation in intervertebral disc degeneration (IDD) and chronic low back pain. Their responsiveness to inflammatory cytokines including IL-1β and TNF-α enables precise study of MMP-13/ADAMTS-5 mediated ECM degradation and annular structural failure. These cells are particularly valuable for evaluating anti-inflammatory compounds and tissue-engineered constructs for ECM restoration and mechanical stability in disc models.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).